Literature DB >> 6148278

Velamentous insertion of the umbilical cord and vasa previa.

J Paavonen, K Jouttunpää, P Kangasluoma, P Aro, P K Heinonen.   

Abstract

We report 31 cases with velamentous insertion of the umbilical cord of whom two had coexistent vasa previa. The prevalence of the former was 0.22% and of the latter 0.014%. Perinatal mortality was low, 3.2%, but there was a high rate of complications during pregnancy, such as threatened abortion, antepartum and intrapartum bleeding, premature delivery and fetal distress. Fifteen patients underwent caesarean section. Four of the term infants were small for gestational age. One infant had congenital malformations. The two cases with vasa previa are described in detail. We conclude that velamentous insertion of the umbilical cord should be kept in mind in the differential diagnosis of fetal distress accompanied with antepartum or intrapartum vaginal bleeding.

Entities:  

Mesh:

Year:  1984        PMID: 6148278     DOI: 10.1016/0020-7292(84)90007-9

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

1.  Twin pregnancy complicated by vasa previa.

Authors:  Cátia Carnide; Mónica Jerónimo; Dolores Faria; Isabel Santos Silva
Journal:  BMJ Case Rep       Date:  2012-12-14

2.  A case of vasa previa diagnosed prenatally, and review of the literature.

Authors:  Atsushi Komatsu; Shiro Kozuma; Shiro Yoshida; Hironobu Hyodo; Takahiro Yamashita; Yoshimasa Kamei; Tomoyuki Fujii; Yuji Taketani
Journal:  J Med Ultrason (2001)       Date:  2010-10-30       Impact factor: 1.314

Review 3.  Vasa Praevia: a descriptive review of existing literature and the evolving role of ultrasound in prenatal screening.

Authors:  Natasha Donnolley; Lesley E Halliday; Yinka Oyelese
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

4.  Placental Structure in Preterm Birth Among HIV-Positive Versus HIV-Negative Women in Kenya.

Authors:  Moses M Obimbo; Yan Zhou; Michael T McMaster; Craig R Cohen; Zahida Qureshi; John Ong'ech; Julius A Ogeng'o; Susan J Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.